Samrat Pharma has reported results for fourth quarter and year ended March 31, 2012.
The company has reported net loss of Rs 1.63 crore for the quarter ended March 31, 2012, against net profit of Rs 0.35 crore for the corresponding period last fiscal. However, total income increased by 46.94% at Rs 15.59 crore during the quarter under review from Rs 10.61 crore in the year-ago period.
For the full year ended March 31, 2012, the company has posted a rise of 181.34% in its net profit at Rs 3.77 crore as compared to Rs 1.34 crore for the same period in the previous year. Total income has increased by 60.14% at Rs 69.55 crore for year under review as compared to Rs 43.43 crore for the period ended March 31, 2011.
